Preliminary tolerance analysis of adjuvant chemotherapy in older patients after resection of stage III colon cancer from the PRODIGE 34-FFCD randomized trial
Authors:
Open Access
- 14 September 2022
- journal article
- research article
- Published by Elsevier in Digestive and Liver Disease
- Vol. 55 (4) , 541-548
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Deficient mismatch repair phenotype is a prognostic factor for colorectal cancer in elderly patientsDigestive and Liver Disease, 2013
- Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trialThe Lancet, 2011
- Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 CountriesAmerican Journal of Epidemiology, 2011
- Management and survival of colorectal cancer in the elderly in population-based studiesEuropean Journal of Cancer, 2007
- Pooled Analysis of Safety and Efficacy of Oxaliplatin Plus Fluorouracil/Leucovorin Administered Bimonthly in Elderly Patients With Colorectal CancerJournal of Clinical Oncology, 2006
- Simplifying Detection of Cognitive Impairment: Comparison of the Mini‐Cog and Mini‐Mental State Examination in a Multiethnic SampleJournal of the American Geriatrics Society, 2005
- Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon CancerNew England Journal of Medicine, 2004
- A Pooled Analysis of Adjuvant Chemotherapy for Resected Colon Cancer in Elderly PatientsNew England Journal of Medicine, 2001
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990
- Measuring the quality of life of cancer patientsJournal of Chronic Diseases, 1981